A randomized phase II study of durvalumab and tremelimumab compared to doxorubicin in patients with advanced or metastatic soft tissue sarcoma (MEDISARC, AIO-STS 0415).

被引：0
|
作者：
Gruenwald, Viktor
Bauer, Sebastian
Hermes, Barbara
Ivanyi, Philipp
Lindner, Lars H.
Pink, Daniel
Reichardt, Peter
Richter, Stephan
Tuchscherer, Armin
机构：
[1] Hannover Med Sch, Dept Hematol Hemostaseol Oncol & Stem Cell Transp, Hannover, Germany
[2] Univ Hosp Essen, West German Canc Ctr, Essen, Germany
[3] Univ Klinikum Tubingen, Tubingen, Germany
[4] Ludwig Maximilians Univ Munchen, Univ Hosp, Munich, Germany
[5] Helios Klinikum Bad Saarow, Bad Saarow Pieskow, Germany
[6] HELIOS Klinikum Berlin Buch, Berlin, Germany
[7] Univ Hosp Carl Gustav Carus, Dresden, Germany
[8] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS11075
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A Randomized Phase II Study of Durvalumab and Tremelimumab Compared to Doxorubicin in Patients with Advanced or Metastatic Soft Tissue Sarcoma (Medisarc, AIO-STS-0415)
    Gruenwald, Viktor
    Ivanyi, Philipp
    Hermes, Barbara
    Tuchscherer, Armin
    Pink, Daniel
    Bauer, Sebastian
    Lindner, Lars
    Augustin, Marinela
    Blocks, Andreas
    Richter, Stephan
    Reichardt, Peter
    Crysandt, Martina
    Hipper, Annette
    Fischer, Marc
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 173 - 173
  • [2] A randomized phase II study of durvalumab and tremelimumab compared to doxorubicin in patients with advanced or metastatic soft tissue sarcoma (MEDISARC, AIOSTS-0415)
    Gruenwald, V.
    ANNALS OF ONCOLOGY, 2023, 34 : S1331 - S1332
  • [3] Durvalumab and tremelimumab versus doxorubicin in previously untreated patients with advanced or metastatic soft tissue sarcoma: Patient-reported outcomes (PROs) of the randomized phase II MEDISARC study (AIO-STS-0415).
    Gruwald, Viktor
    Hermes, Barbara
    Tuchscherer, Armin
    Bauer, Sebastian
    Hamacher, Rainer
    Pink, Daniel
    Lindner, Lars H.
    Groeschel, Stefan
    Reichardt, Peter
    Richter, Stephan
    Oing, Christoph
    Augustin, Marinela
    Crysandt, Martina Margrit
    Kortuem, Martin
    Kasper, Bernd
    Fischer, Marc
    Ivanyi, Philipp
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Pemetrexed in patients with refractory soft tissue sarcoma: A non-comparative multicenter phase II study of the German Sarcoma Group AIO-STS 005
    J. T. Hartmann
    S. Bauer
    G. Egerer
    M. S. Horger
    H.-G. Kopp
    V. Grünwald
    F. Mayer
    Investigational New Drugs, 2013, 31 : 167 - 174
  • [5] Pemetrexed in patients with refractory soft tissue sarcoma: A non-comparative multicenter phase II study of the German Sarcoma Group AIO-STS 005
    Hartmann, J. T.
    Bauer, S.
    Egerer, G.
    Horger, M. S.
    Kopp, H. -G.
    Gruenwald, V.
    Mayer, F.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (01) : 167 - 174
  • [6] Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS)
    Revathi Suppiah
    Laura Wood
    Paul Elson
    George T. Budd
    Investigational New Drugs, 2006, 24 : 509 - 514
  • [7] Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS)
    Suppiah, Revathi
    Wood, Laura
    Elson, Paul
    Budd, George T.
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (06) : 509 - 514
  • [8] Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS).
    Suppiah, R
    Budd, GT
    Wood, L
    Elson, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 831S - 831S
  • [9] Interim safety analysis of AIO-STS 002 palliative randomized phase II metronomic trofosfamide trial in elderly patients with soft tissue SARCOMAS
    Hartmann, J.
    Gruenwald, V.
    Meisinger, I.
    Reichardt, P.
    Kopp, H. -G.
    Pintoffl, J.
    Schaedel, S.
    Hochhaus, A.
    Mayer, F.
    Bauer, S.
    ONKOLOGIE, 2008, 31 : 145 - 145
  • [10] Phase IB/II trial of durvalumab plus doxorubicin combination in patients with advanced soft-tissue sarcoma
    Cho, Hee Jin
    Sim, Nam Suk
    Shin, Su-Jin
    Yun, Kum-Hee
    Lee, Young Han
    Jun, Hyun Jung
    Rha, Sun Young
    Kim, Hyo Song
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345